Skip to main content

Find Clinical Trials

Home
Conditions
SHANK3 Haploinsufficiency

Clinical trial condition

SHANK3 Haploinsufficiency

Explore clinical trials studying SHANK3 Haploinsufficiency. Study availability and eligibility vary by location and protocol.

3 public trials 1 recruiting study

Refine in advanced search Browse all conditions

SHANK3 Haploinsufficiency trial results

Recruiting

JAG201 Gene Therapy Study in Children & Adults With SHANK3 Haploinsufficiency

NCT06662188

Conditions: Phelan-McDermid Syndrome, SHANK3 Haploinsufficiency, Telomeric 22q13 Monosomy Syndrome
Locations: Rush University Chicago, Illinois, United States

Boston Children's Hospital Boston, Massachusetts, United States

Seaver Autism Center at Mount Sinai New York, United States

View Trial Details

Enrolling by Invitation

Long-Term Follow-Up Study for RB001 Gene Therapy Study in Children With SHANK3-related Phelan McDermid Syndrome (PMS)

NCT07690527

Conditions: Phelan-McDermid Syndrome, SHANK3 Haploinsufficiency, Telomeric 22q13 Monosomy Syndrome
Locations: Peking University First Hospital Beijing, China

View Trial Details

Active, Not Recruiting

RB001 Gene Therapy Study in Children With SHANK3-related Phelan-McDermid Syndrome (PMS)

NCT07014020

Conditions: Phelan-McDermid Syndrome, SHANK3 Haploinsufficiency, Telomeric 22q13 Monosomy Syndrome
Locations: Peking University First Hospital Beijing, Beijing Municipality, China

View Trial Details